Journal of the American Chemical Society
Page 12 of 15
Biology, and Medicinal Potential of Narciclasine and its
13. (a) Ma, D.; Pignanelli, C.; Tarade, D.; Gilbert, T.; Noel, M.;
1
2
3
4
5
6
7
8
9
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
6
Congeners. Chem. Rev. 2008, 108, 1982. (c) Fürst, R.
Narciclasine - an Amaryllidaceae Alkaloid with Potent Antitumor
and Anti-Inflammatory Properties. Planta Med. 2016, 82, 1389.
Mansour, F.; Adams, S.; Dowhayko, A.; Stokes, K.; Vshyvenko,
S.; Hudlicky, T.; McNulty, J.; Pandey, S. Cancer Cell
Mitochondria Targeting by Pancratistatin Analogs is Dependent
on Functional Complex II and III. Sci. Rep. 2017, 7, 42957. (b)
Kekre, N.; Griffin, C.; McNulty, J.; Pandey, S. Pancratistatin
causes early activation of caspase-3 and the flipping of
phosphatidyl serine followed by rapid apoptosis specifically in
human lymphoma cells. Cancer Chemother. Pharmacol. 2005,
56, 29.
(
d) He, M. M.; Qu, C. R.; Gao, O. D.; Hu, X. M.; Hong, X. C.
Biological and pharmacological activities of amaryllidaceae
alkaloids. RSC Adv. 2015, 5, 16562. (d) Ghavre, M.; Froese, J.;
Pour, M.; Hudlicky, T. Synthesis of Amaryllidaceae Constituents
and Unnatural Derivatives. Angew. Chem., Int. Ed. 2016, 55,
5
642.
7
.
(a) Pettit, G. R.; Pettit, G. R., III; Backhaus, R. A.; Boyd, M. R.;
Meerow, A. W. Antineoplastic Agents, 256. Cell Growth
Inhibitory Isocarbostyrils from Hymenocallis. J. Nat. Prod. 1993,
14. Carrasco, L.; Fresno, M.; Vazquez, D. Location Of Resistance To
The Alkaloid Narciclasie In The 60S Ribosomal Subunit. FEBS
Lett. 1975, 52, 236.
15. Garreau de Loubresse, N.; Prokhorova, I.; Holtkamp, W.;
Rodnina, M. V.; Yusupova, G.; Yusupov, M. Structural basis for
the inhibition of the eukaryotic ribosome. Nature 2014, 513, 517.
16. Pettit, G. R.; Pettit III, G. R.; Backhaus, R. A.; Boettner, F. E.
Antineoplastic Agents, 294. Variations in the Formation of
Pancratistatin and Related Isocarbostyrils in Hymenocallis
littoralis. J. Nat. Prod. 1995, 58, 37.
17. Backhaus, R. A.; Pettit III, G. R.; Huang, D.-S.; Pettit, G. R.;
Groszek, G.; Odgers, J. C.; Ho, J.; Meerow, A. Biosynthesis of
the Antineoplastic Pancratistatin Following Tissue Culture of
Hymenocallis Littoralis (Amaryllidaceae) Acta Hortic. 1992, 306,
364.
18. (a) For an overview of several isolation methods, see: Ref 6b. (b)
For the most recent optimized procedure, see: Borra, S.;
Lapinskaite, R.; Kempthorne, C.; Liscombe, D.; McNulty, J.;
Hudlicky, T. Isolation, Synthesis, and Semisynthesis of
Amaryllidaceae Constituents from Narcissus and Galanthus sp.:
De Novo Total Synthesis of 2-epi-Narciclasine. J. Nat. Prod.
2018, 81, 1451.
19. For 7-deoxypancratistatin syntheses, see: (a) Paulsen, H.; Stubbe,
M. Chirale synthese von (+)-lycoricidin. Tetrahedron Lett. 1982,
23, 3171. (b) Keck, G. E.; McHardy, S. F.; Murry, J. A. Total
Synthesis of (+)-7-Deoxypancratistatin: A Radical Cyclization
Approach. J. Am. Chem. Soc. 1995, 117, 7289. (c) Tian, X.;
Maurya, R.; Kꢀnigsberger, K.; Hudlicky, T. Asymmetric Total
Synthesis of (+)-7-Deoxypancratistatin. Synlett 1995, 1125. (d)
Hudlicky, T.; Tian, X.; Konigsberger, K.; Maurya, R.; Rouden, J.;
Fan, B. Toluene Dioxygenase-Mediated cis-Dihydroxylation of
Aromatics in Enantioselective Synthesis. Asymmetric Total
Syntheses of Pancratistatin and 7-Deoxypancratistatin, Promising
Antitumor Agents. J. Am. Chem. Soc. 1996, 118, 10752. (e)
Chida, N.; Jitsuoka, M.; Yamamoto, Y.; Ohtsuka, M.; Ogawa, S.
Total Synthesis of (+)-7-Deoxypancratistatin and (+)-7-Deoxy-
trans-dihydronarciclasine. Heterocycles 1996, 43, 1385. (f) Keck,
G. E.; Wager, T. T.; McHardy, S. F. A Second-Generation
Radical-Based Synthesis of (+)-7-Deoxypancratistatin. J. Org.
Chem. 1998, 63, 9164. (g) Akgun, H.; Hudlicky, T. Total
syntheses of ert-conduramine A and ent-7-deoxypancratistatin.
Tetrahedron Lett. 1999, 40, 3081. (h) Acena, J. L.; Arjona, O.;
Leꢁn, M. A.; Plumet, J. Total Synthesis of (+)-7-
Deoxypancratistatin from Furan. Org. Lett. 2000, 2, 3683. (i)
Hakansson, A. E.; Palmelund, A.; Holm, H.; Madsen, R.
Synthesis of 7‐Deoxypancratistatin from Carbohydrates by the
Use of Olefin Metathesis. Chem. - Eur. J. 2006, 12, 3243. (j)
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
5
6, 1682. (b) Griffin, C.; Hamm, C.; McNulty, J.; Pandey, S.
Pancratistatin induces apoptosis in clinical leukemia samples with
minimal effect on non-cancerous peripheral blood mononuclear
cells. Cancer Cell Int. 2010, 10, 6. (c) Ingrassia, L.; Lefranc, F.;
Dewelle, J.; Pottier, L.; Mathieu, V.; Spiegl-Kreinecker, S.;
Sauvage, S.; El Yazidi, M.; Dehoux, M.; Berger, W.; Van
Quaquebeke, E.; Kiss, R. Structure−Activity Relationship
Analysis of Novel Derivatives of Narciclasine (an Amaryllidaceae
Isocarbostyril Derivative) as Potential Anticancer Agents. J. Med.
Chem. 2009, 52, 1100. (d) Dumont, P.; Ingrassia, L.; Rouzeau, S.;
Ribaucour, F.; Thomas, S.; Roland, I.; Darro, F.; Lefranc, F.;
Kiss, R. The Amaryllidaceae isocarbostyril narciclasine induces
apoptosis by activation of the death receptor and/or mitochondrial
pathways in cancer cells but not in normal fibroblasts. Neoplasia
2007, 9, 766. (e) Pettit, G. R.; Gaddamidi, V.; Herald, D. L.;
Singh, S. B.; Cragg, G. M.; Schmidt, J. M.; Boettner, F. E.;
Williams, M.; Sagawa, Y. Antineoplastic Agents, 120.
Pancratium Littorale. J. Nat. Prod. 1986, 49, 995. (f) Griffin C.,
Karnik A., McNulty J. & Pandey S. Pancratistatin Selectively
Targets Cancer Cell Mitochondria and Reduces Growth of Human
Colon Tumor Xenografts. Mol. Cancer Ther. 2011, 10, 57.
(a) Lefranc, F.; Sauvage, S.; Van Goietsenoven, G.; Mégalizzi,
V.; Lamoral-Theys, D.; Debeir, O.; Spiegl-Kreinecker, S.; Berger,
W.; Mathieu, V.; Decaestecker, C.; Kiss, R. Narciclasine, a plant
growth modulator, activates Rho and stress fibers in glioblastoma
cells. Mol. Cancer Ther. 2009, 8, 1739. (b) Van Goietsenoven, G.;
Hutton, J.; Becker, J. P.; Lallemand, B.; Robert, F.; Lefranc, F.;
Pirker, C.; Vandenbussche, G.; Van Antwerpen, P.; Evidente, A.;
Berger, W.; Prévost, M.; Pelletier, J.; Kiss, R.; Kinzy, T. G.;
Kornienko, A.; Mathieu, V. Targeting of eEF1A with Amarylli-
daceae isocarbostyrils as a strategy to combat melanomas. FASEB
J. 2010, 24, 4575. (c) ref 7c. (d) ref 7e.
8
.
9
.
(a) Van Goietsenoven, G.; Mathieu, V.; Lefranc, F.; Kornienko,
A.; Evidente, A.; Kiss, R. Narciclasine as well as other Amarylli-
daceae isocarbostyrils are promising GTP-ase targeting agents
against brain cancers. Med. Res. Rev. 2013, 33, 439. (b) Ref 7c.
10. Gabrielsen, B.; Monath, T. P.; Huggins, J. W.; Kefauver, D. F.;
Pettit, G. R.; Groszek, G.; Hollingshead, M.; Kirsi, J. J.; Shannon,
W. M.; Schubert, E. M.; DaRe, J.; Ugarkar, B.; Ussery, M. A.;
Phelan, M. J. Antiviral (RNA) Activity of Selected Amaryllida-
ceae Isoquinoline Constituents and Synthesis of Related Sub-
stances. J. Nat. Prod. 1992, 55, 1569.
11. Julien, S. G.; Kim, S. Y.; Brunmeir, R.; Sinnakannu, J. R.; Ge, X.;
Li, H.; Ma, W.; Yaligar, J.; Kn, B. P.; Velan, S. S.; Roder, P. V.;
Zhang, Q.; Sim, C. K.; Wu, J.; Garcia-Miralles, M.; Pouladi, M.
A.; Xie, W.; McFarlane, C.; Han, W.; Xu F. Narciclasine attenu-
ates diet-induced obesity by promoting oxidative metabolism in
skeletal muscle. PLoS Biol. 2017, 15, e1002597.
2. Mikami, M.; Kitahara, M.; Kitano, M.; Ariki, Y.; Mimaki, Y.;
Sashida, Y.; Yamazaki, M.; Yui, S. Suppressive activity of lyco-
ricidinol (narciclasine) against cytotoxicity of neutrophil-derived
calprotectin, and its suppressive effect on rat adjuvant arthritis
model. Biol. Pharm. Bull. 1999, 22, 674. (b) Fuchs, S.; Hsieh, L.
T.; Saarberg, W.; Erdelmeier, C. A.; Wichelhaus, T. A.; Schaefer,
L.; Koch, E.; Fürst, R. Haemanthus coccineus extract and its main
bioactive component narciclasine display profound an-
ti‐inflammatory activities in vitro and in vivo. J. Cell. Mol. Med.
3 3
Zhang, H.; Padwa, A. Application of a stereospecific RhCl(PPh )
decarbonylation reaction for the total synthesis of 7-(±)-
deoxypancratistatin. Tetrahedron Lett. 2006, 47, 3905. (k) Nieto-
García, O.; Lago-Santome, H.; Cagide-Fagín, F.; Ortiz-Lara, J.
C.; Alonso, R. A formal [3+3]-annulation-based approach to
pancratistatins: total synthesis of (±)-7-deoxy-pancratistatin and
its 2-epi and 2,4-diepi analogues. Org. Biomol. Chem. 2012, 10,
825. (l) Cai, S.-L.; Yuan, B.-H.; Jiang, Y.-X.; Lin, G.-Q.; Sun, X.-
W. Asymmetric cinnamylation of N-tert-butanesulfinyl imines
with cinnamyl acetates: total syntheses of (+)-lycoricidine and
(+)-7-deoxypancratistatin. Chem. Commun. 2017, 53, 3520.
1
20. For pancratistatin syntheses, see: (a) Danishefsky, S.; Lee, J. Y.
Total synthesis of (±)-pancratistatin. J. Am. Chem. Soc. 1989, 111,
4829. (b) Tian, X.; Hudlicky, T.; Koenigsberger, K. First Total
2
015, 19, 1021.
ACS Paragon Plus Environment